Variant report

Variant	nsv1064691
Chromosome Location	chr19:53509678-53544965
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:224)
CpG islands
(count:366)
Chromatin interactive
region (count:6)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:224 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr19:53518961-53519336	H1-hESC	embryonic stem cell:	n/a	n/a
2	BHLHE40	chr19:53510493-53510782	GM12878	blood:	n/a	n/a
3	BHLHE40	chr19:53510497-53510963	K562	blood:	n/a	n/a
4	CEBPB	chr19:53520052-53520352	K562	blood:	n/a	n/a
5	CEBPB	chr19:53520045-53520364	IMR90	lung:	n/a	n/a
6	CEBPB	chr19:53520162-53520365	MCF-7	breast:	n/a	n/a
7	CEBPB	chr19:53514645-53514955	HepG2	liver:	n/a	chr19:53514790-53514801
8	CEBPB	chr19:53514683-53514869	A549	lung:	n/a	chr19:53514790-53514801
9	CEBPB	chr19:53514622-53514961	K562	blood:	n/a	chr19:53514790-53514801
10	CEBPB	chr19:53520072-53520352	H1-hESC	embryonic stem cell:	n/a	n/a
11	CEBPB	chr19:53514709-53514946	Hela-S3	cervix:	n/a	chr19:53514790-53514801
12	CTCF	chr19:53523066-53523216	GM12891	blood:	n/a	n/a
13	CTCF	chr19:53520160-53520310	HCPEpiC	choroid plexus:	n/a	n/a
14	CTCF	chr19:53523040-53523190	BJ	skin:	n/a	n/a
15	CTCF	chr19:53523158-53523228	GM13977	blood:	n/a	n/a
16	CTCF	chr19:53523155-53523191	LNCaP	prostate:	n/a	n/a
17	CTCF	chr19:53523020-53523170	GM12874	blood:	n/a	n/a
18	CTCF	chr19:53523000-53523150	HA-sp	spinal cord:	n/a	n/a
19	CTCF	chr19:53523000-53523150	NHEK	skin:	n/a	n/a
20	CTCF	chr19:53522863-53523276	K562	blood:	n/a	n/a
21	CTCF	chr19:53523100-53523250	HCT-116	colon:	n/a	n/a
22	CTCF	chr19:53513788-53514075	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr19:53522989-53523273	K562	blood:	n/a	n/a
24	CTCF	chr19:53523000-53523150	HEK293	kidney:	n/a	n/a
25	CTCF	chr19:53523020-53523170	RPTEC	kidney:	n/a	n/a
26	CTCF	chr19:53522981-53523241	K562	blood:	n/a	n/a
27	CTCF	chr19:53523141-53523173	Spleen_OC	spleen:	n/a	n/a
28	CTCF	chr19:53522895-53523274	H1-hESC	embryonic stem cell:	n/a	n/a
29	CTCF	chr19:53523078-53523235	GM19240	blood:	n/a	n/a
30	CTCF	chr19:53523060-53523210	AG09309	skin:	n/a	n/a
31	CTCF	chr19:53523060-53523210	HEK293	kidney:	n/a	n/a
32	CTCF	chr19:53538670-53538733	GM10248	blood:	n/a	n/a
33	CTCF	chr19:53523080-53523230	NB4	blood:	n/a	n/a
34	CTCF	chr19:53518162-53518286	GM20000	blood:	n/a	n/a
35	CTCF	chr19:53523080-53523230	GM12878	blood:	n/a	n/a
36	CTCF	chr19:53522996-53523308	GM12878	blood:	n/a	n/a
37	CTCF	chr19:53517080-53517230	GM12866	blood:	n/a	n/a
38	CTCF	chr19:53523155-53523182	HepG2	liver:	n/a	n/a
39	CTCF	chr19:53523056-53523245	Gliobla	brain:	n/a	n/a
40	CTCF	chr19:53513920-53514070	K562	blood:	n/a	n/a
41	CTCF	chr19:53517968-53518032	K562	blood:	n/a	n/a
42	CTCF	chr19:53522993-53523208	HepG2	liver:	n/a	n/a
43	CTCF	chr19:53523080-53523230	NHEK	skin:	n/a	n/a
44	CTCF	chr19:53523040-53523190	Hela-S3	cervix:	n/a	n/a
45	CTCF	chr19:53523000-53523150	Hela-S3	cervix:	n/a	n/a
46	CTCF	chr19:53523114-53523192	GM10266	blood:	n/a	n/a
47	CTCF	chr19:53513826-53514079	H1-hESC	embryonic stem cell:	n/a	n/a
48	CTCF	chr19:53523084-53523245	Hela-S3	cervix:	n/a	n/a
49	CTCF	chr19:53523020-53523170	HEEpiC	esophagus:	n/a	n/a
50	CTCF	chr19:53523080-53523230	BE2_C	brain:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:53538687-53538737	IMR90	lung:	fetal
2	chr19:53538687-53538737	A549	lung:	n/a
3	chr19:53541186-53541236	HEK293	kidney:	embryo
4	chr19:53538883-53538933	HRPEpiC	eye:	n/a
5	chr19:53541287-53541337	NHBE	bronchial:	n/a
6	chr19:53540902-53540952	NHDF-neo	bronchial:	n/a
7	chr19:53541287-53541337	HepG2	liver:	n/a
8	chr19:53538687-53538737	NHBE	bronchial:	n/a
9	chr19:53541287-53541337	HEK293	kidney:	embryo
10	chr19:53541287-53541337	HCPEpiC	choroid plexus:	n/a
11	chr19:53541186-53541236	H1-hESC	embryonic stem cell:	embryo
12	chr19:53538883-53538933	PANC-1	pancreas:	n/a
13	chr19:53538883-53538933	HAEpiC	amniotic membrane:	n/a
14	chr19:53538687-53538737	HCPEpiC	choroid plexus:	n/a
15	chr19:53540902-53540952	Hepatocyte	liver:	n/a
16	chr19:53540902-53540952	HRPEpiC	eye:	n/a
17	chr19:53540845-53540895	HPAEpiC	pulmonary alveolar:	n/a
18	chr19:53541186-53541236	AG04450	lung:	fetal
19	chr19:53541287-53541337	NH-A	brain:	n/a
20	chr19:53538687-53538737	NH-A	brain:	n/a
21	chr19:53540902-53540952	U87	brain:	n/a
22	chr19:53541186-53541236	HIPEpiC	eye:	n/a
23	chr19:53540845-53540895	GM12891	blood:	n/a
24	chr19:53541186-53541236	SK-N-SH	brain:	n/a
25	chr19:53541186-53541236	MCF10A-Er-Src	breast:	n/a
26	chr19:53541287-53541337	HUVEC	blood vessel:	n/a
27	chr19:53540845-53540895	PrEC	prostate:	n/a
28	chr19:53540845-53540895	U87	brain:	n/a
29	chr19:53540902-53540952	HRCEpiC	kidney:	n/a
30	chr19:53540902-53540952	AoSMC	blood vessel:	n/a
31	chr19:53540902-53540952	BE2_C	brain:	n/a
32	chr19:53541186-53541236	ovcar-3	ovarian:	n/a
33	chr19:53540902-53540952	AG10803	skin:	n/a
34	chr19:53541287-53541337	HNPCEpiC	eye:	n/a
35	chr19:53541287-53541337	MCF-7	breast:	n/a
36	chr19:53538687-53538737	SK-N-SH_RA	brain:	n/a
37	chr19:53540845-53540895	LNCaP	prostate:	n/a
38	chr19:53538883-53538933	HUVEC	blood vessel:	n/a
39	chr19:53541287-53541337	PrEC	prostate:	n/a
40	chr19:53541287-53541337	IMR90	lung:	fetal
41	chr19:53538883-53538933	GM12878	blood:	n/a
42	chr19:53538883-53538933	HCF	heart:	n/a
43	chr19:53541287-53541337	CMK	blood:	n/a
44	chr19:53540845-53540895	HIPEpiC	eye:	n/a
45	chr19:53540902-53540952	GM12891	blood:	n/a
46	chr19:53541287-53541337	AG09319	gingival:	n/a
47	chr19:53540845-53540895	AG09319	gingival:	n/a
48	chr19:53538687-53538737	HIPEpiC	eye:	n/a
49	chr19:53541186-53541236	HRCEpiC	kidney:	n/a
50	chr19:53538687-53538737	GM12892	blood:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:53514929..53517284-chr19:53527300..53529548,2	MCF-7	breast:
2	chr19:53515874..53517968-chr19:53519511..53521544,2	K562	blood:
3	chr19:53541069..53542606-chr19:53543581..53546044,2	K562	blood:
4	chr10:9353360..9353955-chr19:53525559..53526530,2	MCF-7	breast:
5	chr19:53237008..53239147-chr19:53540786..53542527,2	MCF-7	breast:
6	chr19:53536567..53539141-chr19:53540653..53542425,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZNF816-2	chr19:53540978-53541136	NONHSAT067613
2	lnc-ZNF160-1	chr19:53517843-53519833	ENSG00000251255
3	lnc-ZNF160-1	chr19:53517584-53517806	ENSG00000251255

No data

Variant related genes	Relation type
ENSG00000267943	TF binding region
ERVV-1	TF binding region
ERVV-2	TF binding region
ZNF702P	TF binding region
ENSG00000267943	CpG island
ERVV-1	CpG island
ERVV-2	CpG island
ZNF702P	CpG island
ENSG00000269526	chromatin interactions
ENSG00000242779	chromatin interactions
ENSG00000213020	chromatin interactions
GPR107	miRNA target sites
RNF4	miRNA target sites

Extended variants
information (count: 1213 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:1213 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1661906	chr19:53509678-53509679	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs1650934	chr19:53509699-53509700	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs10403221	chr19:53509707-53509708	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs369008979	chr19:53509734-53509735	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs373437471	chr19:53509801-53509802	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs182427003	chr19:53509860-53509861	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs562909121	chr19:53509959-53509960	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs555819864	chr19:53509965-53509966	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs574901271	chr19:53510009-53510010	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs144800037	chr19:53510020-53510021	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs113083987	chr19:53510050-53510051	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs543223392	chr19:53510086-53510087	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs529479127	chr19:53510091-53510092	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs547706744	chr19:53510094-53510095	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs560068331	chr19:53510144-53510145	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs138698971	chr19:53510148-53510149	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs370798978	chr19:53510207-53510208	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs552121573	chr19:53510232-53510233	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs570028335	chr19:53510242-53510243	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs537054228	chr19:53510244-53510245	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs554824907	chr19:53510250-53510251	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs549454269	chr19:53510251-53510252	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs77237200	chr19:53510273-53510274	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs534802657	chr19:53510289-53510290	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs560944118	chr19:53510304-53510305	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs77777767	chr19:53510317-53510318	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs373781036	chr19:53510318-53510319	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs370484525	chr19:53510320-53510321	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs59058496	chr19:53510332-53510333	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs577431246	chr19:53510352-53510353	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs35129476	chr19:53510428-53510429	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs538504153	chr19:53510436-53510437	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs556839898	chr19:53510513-53510514	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs28561945	chr19:53510589-53510590	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs376177037	chr19:53510594-53510595	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs529876612	chr19:53510626-53510627	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs549642871	chr19:53510635-53510636	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs11667093	chr19:53510645-53510646	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs572878399	chr19:53510651-53510652	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs540346136	chr19:53510687-53510688	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs113256064	chr19:53510703-53510704	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs143628068	chr19:53510733-53510734	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs533577187	chr19:53510770-53510771	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs552060104	chr19:53510774-53510775	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs34597326	chr19:53510825-53510826	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs114054725	chr19:53510835-53510836	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs147503026	chr19:53510842-53510843	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs550412909	chr19:53510860-53510861	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs549144887	chr19:53510861-53510862	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs563834215	chr19:53510886-53510887	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Colorectal cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Melanoma	17363583	CNVD
Breast cancer	21785460	CNVD
Adrenocortical carcinoma	18281524	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:225 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:53497600-53509800	Weak transcription	Right Atrium	heart
2	chr19:53498000-53510400	Weak transcription	Placenta Amnion	Placenta Amnion
3	chr19:53506000-53509800	Weak transcription	HUES48 Cell Line	embryonic stem cell
4	chr19:53507000-53510400	Enhancers	Placenta	Placenta
5	chr19:53508000-53513200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr19:53509600-53509800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
7	chr19:53509600-53509800	Enhancers	K562	blood
8	chr19:53509800-53510200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
9	chr19:53509800-53510200	Weak transcription	K562	blood
10	chr19:53510200-53510400	Enhancers	K562	blood
11	chr19:53510200-53511000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr19:53510400-53510800	Active TSS	Rectal Mucosa Donor 29	rectum
13	chr19:53510400-53511000	Enhancers	Placenta Amnion	Placenta Amnion
14	chr19:53510400-53511200	Enhancers	Dnd41	blood
15	chr19:53510400-53511200	Flanking Active TSS	K562	blood
16	chr19:53510400-53511400	Flanking Active TSS	Placenta	Placenta
17	chr19:53510600-53511600	ZNF genes & repeats	H9 Derived Neuron Cultured Cells	ES cell derived
18	chr19:53510800-53511200	Weak transcription	Right Ventricle	heart
19	chr19:53511000-53511200	Flanking Active TSS	Placenta Amnion	Placenta Amnion
20	chr19:53511000-53511800	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
21	chr19:53511200-53511400	Enhancers	Right Ventricle	heart
22	chr19:53511200-53511800	Bivalent Enhancer	K562	blood
23	chr19:53511200-53512600	Enhancers	Placenta Amnion	Placenta Amnion
24	chr19:53511400-53511800	Active TSS	Placenta	Placenta
25	chr19:53511400-53512000	Weak transcription	Right Ventricle	heart
26	chr19:53511600-53512200	Enhancers	Skeletal Muscle Male	skeletal muscle
27	chr19:53511800-53512000	Flanking Active TSS	Placenta	Placenta
28	chr19:53511800-53512400	Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
29	chr19:53512000-53512200	Active TSS	Placenta	Placenta
30	chr19:53512200-53512400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr19:53512200-53512400	Flanking Active TSS	Placenta	Placenta
32	chr19:53512200-53512400	Enhancers	Right Ventricle	heart
33	chr19:53512400-53512600	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
34	chr19:53512400-53513000	Enhancers	Placenta	Placenta
35	chr19:53512400-53513200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
36	chr19:53512400-53513400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
37	chr19:53512600-53514200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr19:53512600-53518800	Weak transcription	Placenta Amnion	Placenta Amnion
39	chr19:53513000-53513800	Genic enhancers	Placenta	Placenta
40	chr19:53513200-53513400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr19:53513200-53513600	Enhancers	iPS-15b Cell Line	embryonic stem cell
42	chr19:53513400-53514000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr19:53513400-53514200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
44	chr19:53513600-53513800	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
45	chr19:53513800-53514000	Flanking Active TSS	Placenta	Placenta
46	chr19:53513800-53514200	Enhancers	iPS-15b Cell Line	embryonic stem cell
47	chr19:53514000-53514200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
48	chr19:53514000-53516600	Enhancers	Placenta	Placenta
49	chr19:53514200-53518800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
50	chr19:53516600-53517200	Genic enhancers	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links